Disease_category,Disease,Protein,Protein_definition,Method,Nb_SNP,OR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,1.03 [0.91-1.17],0.639400427391239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,DLK1,Protein delta homolog 1,Inverse variance weighted,33,1.09 [0.97-1.24],0.15216178101995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PRELP,Prolargin,Inverse variance weighted,14,0.98 [0.84-1.15],0.830173463567562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,8,0.98 [0.73-1.32],0.907880574993213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,21,0.84 [0.66-1.07],0.160552566536637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,ADM,Pro-adrenomedullin,Inverse variance weighted,4,1.30 [1.00-1.70],0.0516090085491807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CD59,CD59 glycoprotein,Inverse variance weighted,8,1.14 [0.93-1.41],0.201924080439049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,5,1.30 [0.61-2.80],0.496346105350468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,0.67 [0.27-1.64],0.378256499160777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,12,0.75 [0.60-0.94],0.0123483514174832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CST3,Cystatin-C,Inverse variance weighted,13,0.96 [0.82-1.13],0.653596815850853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,RNASE10,Inactive ribonuclease-like protein 10,Inverse variance weighted,27,1.05 [0.98-1.12],0.162476327504735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,23,0.96 [0.84-1.09],0.515134791626004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,DPT,Dermatopontin,Inverse variance weighted,26,0.96 [0.83-1.12],0.63080998963143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,14,1.07 [0.82-1.40],0.618708072941288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CALCA,Calcitonin,Inverse variance weighted,17,0.76 [0.58-0.99],0.0406806215517454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,NPPC,C-type natriuretic peptide,Inverse variance weighted,5,1.17 [0.41-3.33],0.764359695514646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SPINK2,Serine protease inhibitor Kazal-type 2,Inverse variance weighted,34,0.93 [0.83-1.04],0.211738391045116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,49,0.95 [0.88-1.02],0.185577969313663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,23,1.10 [0.95-1.27],0.222515246757383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CTSZ,Cathepsin Z,Inverse variance weighted,16,0.99 [0.84-1.16],0.899636041607515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PI3,Elafin,Inverse variance weighted,20,1.05 [0.89-1.24],0.578807541770307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,RARRES1,Retinoic acid receptor responder protein 1,Inverse variance weighted,34,1.03 [0.95-1.11],0.484535772039357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,KLRK1,NKG2-D type II integral membrane protein,Inverse variance weighted,32,0.98 [0.88-1.09],0.720213628453312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,20,1.04 [0.96-1.13],0.327355861503084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,ITGB6,Integrin beta-6,Inverse variance weighted,24,0.92 [0.80-1.07],0.292975784204516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,AGRP,Agouti-related protein,Inverse variance weighted,20,0.96 [0.79-1.17],0.68720853518114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,NECTIN2,Nectin-2,Inverse variance weighted,8,1.01 [0.86-1.18],0.901726923674252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,75,1.03 [0.98-1.09],0.251153566386297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,NOTCH2,Neurogenic locus notch homolog protein 2,Inverse variance weighted,20,0.95 [0.85-1.07],0.405466197730104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,25,0.96 [0.87-1.05],0.338583023854853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PLXNB2,Plexin-B2,Inverse variance weighted,37,1.02 [0.95-1.09],0.64430689522544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,10,1.40 [0.99-1.98],0.0570621581263414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,4,1.08 [0.73-1.60],0.68899546973928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,1.20 [0.88-1.63],0.242042878614774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CCN4,CCN family member 4,Inverse variance weighted,40,1.07 [0.97-1.18],0.194922390570351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,23,1.04 [0.84-1.28],0.747677602966021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,8,1.36 [0.97-1.90],0.0770490284479781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,DCN,Decorin,Inverse variance weighted,3,1.47 [0.67-3.22],0.331700292490526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,UMOD,Uromodulin,Inverse variance weighted,62,1.10 [1.02-1.19],0.0151975198077119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,FGF23,Fibroblast growth factor 23,Inverse variance weighted,17,1.09 [0.83-1.45],0.527975889910015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Inverse variance weighted,22,1.09 [0.95-1.25],0.221808030004071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,APOA4,Apolipoprotein A-IV,Inverse variance weighted,5,1.14 [0.36-3.60],0.829604132500991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,13,0.96 [0.74-1.25],0.781377557999199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,15,0.94 [0.80-1.10],0.45804774517523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,10,1.17 [0.77-1.78],0.461431063443551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,38,1.00 [0.90-1.10],0.957398000504051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,MMP12,Macrophage metalloelastase,Inverse variance weighted,21,1.02 [0.93-1.11],0.718590557858202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,0.93 [0.76-1.14],0.490420579920059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,GUCA2A,Guanylin,Inverse variance weighted,16,0.86 [0.67-1.10],0.238112832307269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,76,1.04 [0.99-1.10],0.105968306371337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PHLDB1,Pleckstrin homology-like domain family B member 1,Inverse variance weighted,3,1.34 [0.64-2.81],0.436856266982864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PENK,Proenkephalin-A,Inverse variance weighted,21,1.06 [0.90-1.24],0.475275514937386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,28,1.02 [0.93-1.11],0.722168467441886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,5,1.42 [0.70-2.86],0.329586264556404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,0.92 [0.72-1.17],0.491672218946849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,KIAA0319,Dyslexia-associated protein KIAA0319,Inverse variance weighted,17,1.07 [0.95-1.20],0.274979130473511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SEPTIN8,Septin-8,Inverse variance weighted,6,0.93 [0.66-1.30],0.660490662210953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,RBP2,Retinol-binding protein 2,Inverse variance weighted,6,1.00 [0.64-1.58],0.993309830649995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,11,1.16 [0.85-1.59],0.352931902879399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,41,1.04 [0.97-1.11],0.289764997475949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,9,1.47 [0.97-2.23],0.0671433449109037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,FCRL2,Fc receptor-like protein 2,Inverse variance weighted,66,0.94 [0.86-1.03],0.183648504772785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,29,1.00 [0.90-1.11],0.933216998752903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,10,0.80 [0.62-1.03],0.0833499641747673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,GPC1,Glypican-1,Inverse variance weighted,43,0.99 [0.89-1.10],0.888077311028143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.01 [0.84-1.21],0.956378316228592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,26,0.89 [0.78-1.00],0.0495829733198589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,KLK6,Kallikrein-6,Inverse variance weighted,6,1.21 [0.83-1.77],0.313675827075693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,Inverse variance weighted,40,1.05 [0.93-1.19],0.405999051464778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,Wald ratio,1,1.11 [0.32-3.88],0.872500712577801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,24,1.02 [0.87-1.21],0.785384704588295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,29,1.00 [0.89-1.11],0.967145986782048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,15,1.00 [0.84-1.18],0.978229244821659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,29,0.94 [0.85-1.05],0.295116062429342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,19,0.90 [0.79-1.03],0.111568436150849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,6,1.29 [0.94-1.76],0.114171023088686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,15,1.10 [0.81-1.50],0.542759022866391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,6,0.59 [0.37-0.94],0.0253712216054235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,AOC3,Membrane primary amine oxidase,Inverse variance weighted,36,0.96 [0.87-1.07],0.459090611669471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PEAR1,Platelet endothelial aggregation receptor 1,Inverse variance weighted,14,1.20 [0.96-1.50],0.106715305194026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CST6,Cystatin-M,Inverse variance weighted,32,0.90 [0.76-1.06],0.194918669392433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,35,0.89 [0.80-0.98],0.0188884774223246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,RBP5,Retinol-binding protein 5,Inverse variance weighted,5,0.79 [0.39-1.63],0.530212571504865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,16,1.07 [0.88-1.29],0.518929967933232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,7,0.77 [0.45-1.31],0.333723049546135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,19,1.16 [0.95-1.41],0.145528963262409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,IL12A_IL12B,Interleukin-12,Inverse variance weighted,57,0.99 [0.90-1.09],0.805505789917605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,32,0.95 [0.88-1.03],0.185819052960464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,13,0.91 [0.73-1.12],0.366754965616522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,MELTF,Melanotransferrin,Inverse variance weighted,42,0.96 [0.90-1.04],0.322274567291124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,2,0.93 [0.53-1.65],0.812774149007506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,0.89 [0.59-1.36],0.597090471111035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,39,0.94 [0.83-1.06],0.290921100181435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,REN,Renin,Inverse variance weighted,12,1.01 [0.84-1.20],0.939692446927498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,HEPH,Hephaestin,Inverse variance weighted,6,1.14 [0.90-1.45],0.286550141078243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PCDH7,Protocadherin-7,Inverse variance weighted,6,1.00 [0.69-1.45],0.99783006947516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,22,0.95 [0.78-1.15],0.591277043386695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,GM2A,Ganglioside GM2 activator,Inverse variance weighted,26,0.97 [0.89-1.05],0.420877171051168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SPRR3,Small proline-rich protein 3,Inverse variance weighted,17,0.87 [0.74-1.03],0.110569404969201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,MATN2,Matrilin-2,Inverse variance weighted,32,0.92 [0.83-1.01],0.0899943026619434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,NECTIN4,Nectin-4,Inverse variance weighted,12,1.03 [0.86-1.22],0.757860361117728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,RETN,Resistin,Inverse variance weighted,28,1.05 [0.91-1.21],0.479586268169367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,DTNB,Dystrobrevin beta,Inverse variance weighted,4,0.87 [0.44-1.74],0.692115358230721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,31,1.12 [0.89-1.40],0.333782883296228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,16,0.95 [0.81-1.12],0.539555686825108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,1.24 [0.62-2.46],0.540941333438024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,11,0.71 [0.48-1.07],0.101083666288527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,5,1.55 [1.00-2.40],0.049544177404977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,13,1.19 [0.92-1.54],0.188473248202421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,31,0.96 [0.90-1.04],0.327976173429331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,62,1.10 [1.02-1.19],0.0177851804334808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CD200,OX-2 membrane glycoprotein,Inverse variance weighted,15,1.23 [1.02-1.48],0.0320753341679934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,23,0.87 [0.76-1.00],0.0531452672872447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CCL25,C-C motif chemokine 25,Inverse variance weighted,49,0.95 [0.88-1.02],0.168255017580032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,22,1.03 [0.97-1.08],0.360964413241947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PTK7,Inactive tyrosine-protein kinase 7,Wald ratio,1,0.92 [0.34-2.55],0.877549817696633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,63,0.98 [0.90-1.06],0.602550034523934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CHGB,Secretogranin-1,Inverse variance weighted,33,1.05 [0.96-1.14],0.325084792905851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,1.05 [0.95-1.16],0.303432267247098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,1.39 [0.68-2.84],0.366303051826668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,18,0.87 [0.67-1.14],0.312019781658376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PALM2,Paralemmin-2,Inverse variance weighted,9,1.40 [1.13-1.75],0.0022717555593153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,ICAM2,Intercellular adhesion molecule 2,Inverse variance weighted,78,0.93 [0.87-1.00],0.0379083468451282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,MSMB,Beta-microseminoprotein,Inverse variance weighted,92,0.96 [0.91-1.01],0.102188779226787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,EDN1,Endothelin-1,Inverse variance weighted,3,1.34 [1.02-1.77],0.0386355620213745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,FBLN2,Fibulin-2,Inverse variance weighted,17,0.82 [0.71-0.95],0.0074183873699853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,FABP4,"Fatty acid-binding protein, adipocyte",Inverse variance weighted,2,0.86 [0.35-2.10],0.739652149672591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.76 [0.49-1.18],0.226222078259383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,6,1.00 [0.79-1.26],0.991281810096216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,RNASE4,Ribonuclease 4,Inverse variance weighted,13,1.00 [0.84-1.19],0.988164103993585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,ALCAM,CD166 antigen,Inverse variance weighted,11,0.86 [0.69-1.09],0.215499289718056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,REG1A,Lithostathine-1-alpha,Inverse variance weighted,26,1.00 [0.87-1.15],0.998599674641963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,22,1.08 [0.85-1.37],0.513641989225233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,THBD,Thrombomodulin,Inverse variance weighted,16,1.14 [0.97-1.33],0.117292318326944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,30,1.08 [0.97-1.21],0.172517993410953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,11,1.24 [0.90-1.70],0.19230497201139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,15,1.14 [0.94-1.38],0.178579329050444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,1.05 [0.66-1.69],0.830772591672545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,5,1.07 [0.58-1.98],0.834212220249184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,GRN,Progranulin,Inverse variance weighted,46,1.01 [0.92-1.11],0.776435917947381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,8,1.07 [0.75-1.52],0.722015707362444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,IL16,Pro-interleukin-16,Inverse variance weighted,20,1.07 [0.94-1.22],0.298947837672182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,1.09 [0.90-1.32],0.385692260222625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CSTB,Cystatin-B,Inverse variance weighted,25,1.06 [0.95-1.18],0.316882697176348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,15,1.03 [0.86-1.24],0.763331558851706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CTSB,Cathepsin B,Inverse variance weighted,50,1.01 [0.93-1.10],0.757197240520981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CD48,CD48 antigen,Inverse variance weighted,32,0.95 [0.87-1.04],0.240759499968704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,31,1.03 [0.87-1.21],0.765056658547591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,NPY,Pro-neuropeptide Y,Inverse variance weighted,18,1.01 [0.79-1.29],0.961766552939572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,COLEC12,Collectin-12,Inverse variance weighted,13,1.16 [0.93-1.44],0.200249303634981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,MFAP5,Microfibrillar-associated protein 5,Inverse variance weighted,2,1.70 [0.86-3.36],0.125105869371363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,17,1.11 [0.86-1.45],0.412474965474904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SPON1,Spondin-1,Inverse variance weighted,25,0.98 [0.83-1.16],0.843298357558814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,20,0.96 [0.82-1.13],0.662377317666737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,42,1.03 [0.93-1.16],0.555982612139964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SCG2,Secretogranin-2,Inverse variance weighted,3,1.00 [0.35-2.87],0.995525350963682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,16,0.91 [0.73-1.13],0.381627032428734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SEMA3F,Semaphorin-3F,Inverse variance weighted,46,0.98 [0.81-1.18],0.813598475984468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,14,1.05 [0.88-1.27],0.57211391802565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CD7,T-cell antigen CD7,Inverse variance weighted,12,1.01 [0.90-1.13],0.888899760338993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,30,1.04 [0.91-1.19],0.53378221520558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CA4,Carbonic anhydrase 4,Inverse variance weighted,25,0.96 [0.86-1.08],0.514723024908678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,VWC2,Brorin,Inverse variance weighted,35,1.04 [0.90-1.20],0.605551298553721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,FOLR2,Folate receptor beta,Inverse variance weighted,16,1.21 [0.96-1.51],0.100241599308901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CD99,CD99 antigen,Inverse variance weighted,4,1.00 [0.60-1.67],0.988017705640616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.47 [0.18-1.20],0.113365309453165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,0.98 [0.78-1.22],0.82700657467668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,DRAXIN,Draxin,Inverse variance weighted,38,0.98 [0.89-1.08],0.704296282956184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,MDK,Midkine,Inverse variance weighted,19,1.04 [0.84-1.30],0.712530838959441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,44,1.00 [0.93-1.07],0.889267327311292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.15 [0.81-1.63],0.448206046896462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,38,1.06 [0.98-1.15],0.131816703069525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CD300E,CMRF35-like molecule 2,Inverse variance weighted,36,1.00 [0.88-1.13],0.991493599865628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,35,1.00 [0.93-1.08],0.911095737335667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,FSTL1,Follistatin-related protein 1,Inverse variance weighted,15,1.24 [0.98-1.58],0.0756427779049039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,RGMA,Repulsive guidance molecule A,Inverse variance weighted,47,1.02 [0.92-1.13],0.70203869421148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,24,1.02 [0.90-1.16],0.740005402705478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,27,1.12 [0.92-1.37],0.247682524054025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SHISA5,Protein shisa-5,Inverse variance weighted,16,1.51 [1.09-2.09],0.0131166969384223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CD46,Membrane cofactor protein,Inverse variance weighted,3,0.87 [0.55-1.37],0.542832385468719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,40,1.04 [0.92-1.18],0.535099567055076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CX3CL1,Fractalkine,Inverse variance weighted,23,1.15 [0.92-1.43],0.220499918291379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CDH6,Cadherin-6,Inverse variance weighted,34,0.98 [0.90-1.07],0.639578080669477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CD27,CD27 antigen,Inverse variance weighted,18,1.05 [0.91-1.22],0.512089531036264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,OCLN,Occludin,Inverse variance weighted,3,1.46 [0.95-2.25],0.0847600926476147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,35,1.12 [0.98-1.29],0.0989972900662813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,INHBB,Inhibin beta B chain,Inverse variance weighted,16,1.11 [0.85-1.44],0.441356086801076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,15,1.08 [0.75-1.55],0.67254216899393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,5,1.11 [0.66-1.88],0.682985082498809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CCN3,CCN family member 3,Inverse variance weighted,20,1.07 [0.86-1.32],0.563187160620391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,15,0.86 [0.68-1.08],0.203317449129329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CAPG,Macrophage-capping protein,Inverse variance weighted,34,1.02 [0.92-1.12],0.727078553477904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CD83,CD83 antigen,Inverse variance weighted,19,1.10 [0.89-1.37],0.369443022339135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,38,1.02 [0.93-1.12],0.709112287582377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,Inverse variance weighted,41,0.96 [0.88-1.05],0.403239946462196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,ANXA5,Annexin A5,Inverse variance weighted,2,0.79 [0.47-1.33],0.381307189886999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,8,0.98 [0.83-1.16],0.836389036863808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PGF,Placenta growth factor,Inverse variance weighted,8,0.58 [0.33-1.04],0.0668816786537496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,36,1.13 [0.99-1.29],0.0603028826982738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,NXPH3,Neurexophilin-3,Inverse variance weighted,19,0.91 [0.80-1.03],0.124675938046483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,KLK4,Kallikrein-4,Inverse variance weighted,20,1.06 [0.94-1.19],0.319030393945633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,XG,Glycoprotein Xg,Inverse variance weighted,2,0.44 [0.16-1.22],0.115269244242969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,24,1.14 [1.00-1.32],0.0581972392452594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,16,1.00 [0.83-1.20],0.974387965577972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,24,0.89 [0.75-1.05],0.165230215601946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CD55,Complement decay-accelerating factor,Inverse variance weighted,27,1.09 [0.98-1.22],0.110478815623766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SPINK5,Serine protease inhibitor Kazal-type 5,Inverse variance weighted,31,1.09 [0.98-1.21],0.108635831598966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,ANGPT2,Angiopoietin-2,Inverse variance weighted,11,0.88 [0.71-1.11],0.282500499799869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,MMP10,Stromelysin-2,Inverse variance weighted,30,1.00 [0.87-1.14],0.950711822740774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,AGRN,Agrin,Inverse variance weighted,31,1.15 [0.98-1.34],0.0874721404668175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,HNMT,Histamine N-methyltransferase,Inverse variance weighted,32,1.02 [0.94-1.10],0.649991408914252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1.02 [0.95-1.09],0.605357759204099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SPINK6,Serine protease inhibitor Kazal-type 6,Inverse variance weighted,14,0.88 [0.72-1.09],0.245274619818882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SPON2,Spondin-2,Inverse variance weighted,8,0.98 [0.77-1.26],0.885609912033149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,F3,Tissue factor,Inverse variance weighted,26,1.05 [0.89-1.24],0.553422322052299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,10,1.06 [0.68-1.65],0.787318347186512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,43,0.94 [0.86-1.02],0.129725235368379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,RNASE6,Ribonuclease K6,Inverse variance weighted,20,1.11 [0.99-1.26],0.0787054894064971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,4,1.00 [0.63-1.58],0.984072421316815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,61,1.04 [0.97-1.11],0.281512315754127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,VEGFD,Vascular endothelial growth factor D,Inverse variance weighted,7,1.19 [0.88-1.60],0.268514150069628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PI16,Peptidase inhibitor 16,Inverse variance weighted,36,0.93 [0.84-1.03],0.179343699575712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,KIRREL2,Kin of IRRE-like protein 2,Inverse variance weighted,29,1.01 [0.90-1.13],0.912411173964662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,GFRA3,GDNF family receptor alpha-3,Inverse variance weighted,40,0.95 [0.83-1.09],0.451059243317054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PTPRR,Receptor-type tyrosine-protein phosphatase R,Inverse variance weighted,5,0.92 [0.48-1.74],0.791098265686611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,1.73 [0.45-6.62],0.422263152058298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,19,1.01 [0.86-1.19],0.865757552618718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CFD,Complement factor D,Inverse variance weighted,12,1.19 [1.00-1.42],0.0478170590011813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,HSPB6,Heat shock protein beta-6,Inverse variance weighted,5,1.10 [0.50-2.43],0.818389304325232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CLEC10A,C-type lectin domain family 10 member A,Inverse variance weighted,34,0.93 [0.86-1.01],0.0756051618452784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,13,1.20 [1.01-1.42],0.0383039981619603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.02 [0.94-1.11],0.669207073386076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,EBI3_IL27,Interleukin-27,Inverse variance weighted,37,0.97 [0.85-1.10],0.638624686462341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.09 [0.83-1.43],0.549103105496045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,IGFBP1,Insulin-like growth factor-binding protein 1,Wald ratio,1,0.85 [0.25-2.90],0.798022152551234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,1.02 [0.74-1.40],0.916239483396723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SDC1,Syndecan-1,Inverse variance weighted,14,1.07 [0.84-1.38],0.581384327276029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,2.32 [1.34-4.02],0.0027507067661895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,6,0.85 [0.67-1.08],0.182809573278051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,KITLG,Kit ligand,Inverse variance weighted,31,1.10 [0.92-1.31],0.294929806111956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,3,0.87 [0.52-1.45],0.597920894949555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,FABP6,Gastrotropin,Inverse variance weighted,5,0.76 [0.45-1.30],0.321762491166654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,17,1.01 [0.83-1.22],0.921676550759228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.95 [0.61-1.50],0.840073718565812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,NPPB,Natriuretic peptides B,Inverse variance weighted,3,0.76 [0.57-1.03],0.07726599910387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,17,1.09 [0.94-1.27],0.255659099778351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,50,1.04 [0.96-1.13],0.309141530571848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,13,0.73 [0.40-1.32],0.297742694181344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,14,0.96 [0.72-1.28],0.769786481387619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,0.77 [0.44-1.34],0.355707146538867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,13,0.88 [0.66-1.18],0.40300092740235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.58 [0.23-1.43],0.233243887056834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,28,1.00 [0.92-1.08],0.973371010969547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,28,1.04 [0.89-1.21],0.614829822955822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,6,1.11 [0.70-1.76],0.647832331002329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,15,0.96 [0.77-1.19],0.685449718695791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CA14,Carbonic anhydrase 14,Inverse variance weighted,21,1.20 [0.94-1.53],0.137761728493659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,18,1.02 [0.85-1.21],0.857628199334537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,FSTL3,Follistatin-related protein 3,Inverse variance weighted,7,1.06 [0.68-1.66],0.788902361684931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,20,0.90 [0.76-1.06],0.198840167668028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,LGALS3,Galectin-3,Inverse variance weighted,42,1.08 [0.96-1.21],0.194877031025763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,31,0.97 [0.87-1.08],0.57317968196191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,LCN15,Lipocalin-15,Inverse variance weighted,22,1.02 [0.91-1.15],0.687723928326334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,12,1.09 [0.89-1.33],0.417345986354303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,0.95 [0.84-1.07],0.41492154789226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,24,1.04 [0.89-1.23],0.606440683862407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,8,1.13 [0.91-1.41],0.263502814467926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,EFNA1,Ephrin-A1,Inverse variance weighted,15,0.95 [0.82-1.10],0.473267595235417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PRSS2,Trypsin-2,Inverse variance weighted,22,1.02 [0.85-1.22],0.865082169355686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,19,0.91 [0.65-1.26],0.560174710155018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,28,1.00 [0.91-1.10],0.966124672951149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,42,0.98 [0.89-1.07],0.649231125277435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,TACSTD2,Tumor-associated calcium signal transducer 2,Inverse variance weighted,36,0.99 [0.91-1.07],0.753589424781165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,17,1.07 [0.91-1.26],0.424908284141422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,NRP1,Neuropilin-1,Inverse variance weighted,26,0.92 [0.81-1.06],0.247818622162688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SLITRK2,SLIT and NTRK-like protein 2,Inverse variance weighted,12,1.11 [0.83-1.47],0.491704779073658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,EPHA4,Ephrin type-A receptor 4,Inverse variance weighted,8,1.19 [0.79-1.80],0.398241777512189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,0.90 [0.74-1.08],0.246710285446179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,BMP10,Bone morphogenetic protein 10,Inverse variance weighted,29,1.08 [0.94-1.25],0.273105523806342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SLC39A14,Zinc transporter ZIP14,Inverse variance weighted,5,0.88 [0.47-1.65],0.683786521274735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,KLK8,Kallikrein-8,Inverse variance weighted,17,0.96 [0.80-1.14],0.61927077015078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,13,0.82 [0.64-1.04],0.10207992585535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,24,1.02 [0.87-1.20],0.802687253556626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,LMNB2,Lamin-B2,Inverse variance weighted,9,0.80 [0.52-1.25],0.327846441376199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,0.96 [0.85-1.07],0.452119201226661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CCL20,C-C motif chemokine 20,Inverse variance weighted,8,0.93 [0.64-1.35],0.698417885314142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,GDF15,Growth/differentiation factor 15,Inverse variance weighted,14,1.04 [0.78-1.39],0.797484781277879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PRSS8,Prostasin,Inverse variance weighted,19,1.08 [0.85-1.37],0.522772144839209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,12,0.93 [0.79-1.09],0.378346256995752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,40,1.00 [0.92-1.09],0.986259948286928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,ULBP2,UL16-binding protein 2,Inverse variance weighted,37,0.98 [0.91-1.05],0.535054003484744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,18,1.00 [0.76-1.33],0.973899846374363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SIGLEC1,Sialoadhesin,Inverse variance weighted,31,1.08 [0.95-1.23],0.236856565872667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,LGALS7_LGALS7B,Galectin-7,Inverse variance weighted,24,0.94 [0.75-1.16],0.540192910112121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,66,1.07 [1.01-1.14],0.0212327141264754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,FOLR1,Folate receptor alpha,Inverse variance weighted,10,1.38 [0.97-1.95],0.0706885175427818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,13,1.05 [0.98-1.12],0.204677176574479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,KLK11,Kallikrein-11,Inverse variance weighted,19,1.11 [0.99-1.24],0.0716948488499001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,NUCB2,Nucleobindin-2,Inverse variance weighted,28,1.08 [0.95-1.23],0.239690147984146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,21,1.18 [0.99-1.39],0.059349221671102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,28,1.08 [0.96-1.22],0.201824892315023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.66 [1.05-2.61],0.0304183469746669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,75,0.93 [0.87-1.00],0.0353670491003827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,34,1.00 [0.89-1.12],0.995196625568554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,OGN,Mimecan,Inverse variance weighted,37,1.00 [0.89-1.13],0.957275829669335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,24,1.01 [0.83-1.23],0.893412880327753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,25,0.89 [0.70-1.13],0.347358085041737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,11,0.92 [0.74-1.13],0.418283302041328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,42,0.87 [0.77-0.98],0.0270301065801803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,STC1,Stanniocalcin-1,Inverse variance weighted,11,0.99 [0.78-1.26],0.935100001156641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,1.20 [1.02-1.41],0.0281920924289448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CTSO,Cathepsin O,Inverse variance weighted,22,1.15 [0.96-1.38],0.128060631030784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CA9,Carbonic anhydrase 9,Inverse variance weighted,11,0.79 [0.60-1.04],0.0921057079132342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,8,0.85 [0.65-1.12],0.242950031668055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,FAM3B,Protein FAM3B,Inverse variance weighted,26,1.02 [0.93-1.11],0.719085251731078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,19,0.98 [0.80-1.19],0.808569014108147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CHGA,Chromogranin-A,Inverse variance weighted,8,0.87 [0.69-1.10],0.245038472959053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,TGFA,Protransforming growth factor alpha,Inverse variance weighted,11,1.12 [0.80-1.57],0.499164983604216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,24,1.06 [0.90-1.25],0.495923265288104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,16,1.06 [0.84-1.35],0.627691747436199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CTSL,Cathepsin L1,Inverse variance weighted,29,0.96 [0.80-1.14],0.617402974949695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,13,1.05 [0.89-1.25],0.569380848186905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.42 [0.80-2.50],0.231672516286263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PRG2,Bone marrow proteoglycan,Inverse variance weighted,40,1.07 [0.91-1.26],0.407805758187474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,19,1.07 [0.88-1.30],0.489471701313858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,28,0.94 [0.83-1.07],0.368717777567079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PDCD1,Programmed cell death protein 1,Inverse variance weighted,24,0.93 [0.79-1.10],0.375585074046815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,DLL1,Delta-like protein 1,Inverse variance weighted,13,0.92 [0.66-1.29],0.62580124023175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,ELN,Elastin,Inverse variance weighted,12,0.91 [0.65-1.29],0.604964861138872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,17,1.33 [1.12-1.57],0.0008088238905137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,DKK3,Dickkopf-related protein 3,Inverse variance weighted,28,1.01 [0.91-1.12],0.854455551652556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,6,1.08 [0.81-1.44],0.597026771015555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,17,1.05 [0.90-1.22],0.534722687032402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,37,1.00 [0.92-1.10],0.929344610744112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,10,1.19 [0.92-1.55],0.183595662715854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CD164,Sialomucin core protein 24,Inverse variance weighted,11,1.09 [0.87-1.37],0.451547602612984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,FAM3D,Protein FAM3D,Inverse variance weighted,56,1.09 [1.00-1.19],0.0428215590691415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PSAP,Prosaposin,Inverse variance weighted,13,0.95 [0.79-1.14],0.566536197243615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,27,1.04 [0.92-1.17],0.565472696284977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,RSPO3,R-spondin-3,Inverse variance weighted,11,1.10 [0.85-1.42],0.467033538829991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,11,1.04 [0.67-1.62],0.853416414884318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,34,1.23 [1.03-1.47],0.0240421974729345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,XCL1,Lymphotactin,Inverse variance weighted,47,0.98 [0.90-1.06],0.577820205113154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,8,0.90 [0.61-1.33],0.584819669771002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,30,0.83 [0.70-0.99],0.0387350112225038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,GCG,Pro-glucagon,Inverse variance weighted,2,1.67 [0.15-19.06],0.681699887175609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,AREG,Amphiregulin,Inverse variance weighted,7,1.09 [0.81-1.46],0.585751095364494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,IL17C,Interleukin-17C,Inverse variance weighted,8,1.13 [0.82-1.57],0.447157522086733
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PTPRS,Receptor-type tyrosine-protein phosphatase S,Inverse variance weighted,26,0.94 [0.84-1.05],0.25694446370498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PALM,Paralemmin-1,Inverse variance weighted,10,0.88 [0.69-1.12],0.310623396470125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,16,1.00 [0.89-1.13],0.95008705913068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,41,0.94 [0.81-1.08],0.347191042689683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,41,1.02 [0.95-1.10],0.55058542424632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,0.94 [0.73-1.22],0.651717371522214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CD276,CD276 antigen,Inverse variance weighted,47,1.01 [0.93-1.10],0.75672389840836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,14,1.00 [0.83-1.21],0.999061802547775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,18,0.92 [0.78-1.09],0.330871001470546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,18,0.95 [0.80-1.13],0.578647572993584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,BSG,Basigin,Inverse variance weighted,8,1.12 [0.76-1.65],0.574649967863405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,5,1.53 [0.94-2.49],0.0866878322693575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,23,1.05 [0.96-1.16],0.27751634704553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,9,1.40 [1.02-1.93],0.0383444522341023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,1.09 [0.97-1.23],0.147444380369373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,TMPRSS11D,Transmembrane protease serine 11D,Inverse variance weighted,4,0.92 [0.62-1.36],0.675790359760766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,24,1.07 [0.90-1.26],0.456581027324148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,11,0.92 [0.78-1.09],0.333557843697733
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,23,1.01 [0.84-1.20],0.955636969100581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,22,0.95 [0.79-1.14],0.598028408393871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,15,0.96 [0.79-1.18],0.726118323704407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,AMBP,Protein AMBP,Inverse variance weighted,5,0.93 [0.60-1.45],0.753786058087863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,TCN2,Transcobalamin-2,Inverse variance weighted,66,0.97 [0.91-1.03],0.303028208961456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,22,1.07 [0.98-1.18],0.133611837725891
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,0.99 [0.66-1.50],0.966837212801315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,36,1.13 [1.02-1.26],0.0164049610960316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,1.11 [0.92-1.33],0.264981147473609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,FAM3C,Protein FAM3C,Inverse variance weighted,5,1.98 [1.20-3.26],0.0071997428870563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,WNT9A,Protein Wnt-9a,Inverse variance weighted,7,0.97 [0.65-1.44],0.862196253413638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,RGMB,RGM domain family member B,Inverse variance weighted,10,1.08 [0.74-1.57],0.687078043431133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CLMP,CXADR-like membrane protein,Inverse variance weighted,15,1.01 [0.87-1.18],0.859290523683169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,1.10 [1.00-1.21],0.0422893558467376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SCGB1A1,Uteroglobin,Inverse variance weighted,49,1.00 [0.88-1.14],0.950451733542693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,BOC,Brother of CDO,Inverse variance weighted,15,1.07 [0.88-1.29],0.503749118014822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.00 [0.63-1.60],0.992394324562944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PREB,Prolactin regulatory element-binding protein,Wald ratio,1,1.58 [0.40-6.20],0.513701217367128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,HIP1R,Huntingtin-interacting protein 1-related protein,Inverse variance weighted,2,1.47 [0.94-2.29],0.0911738231942447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,TFF1,Trefoil factor 1,Inverse variance weighted,14,0.91 [0.77-1.08],0.302801032689347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CD160,CD160 antigen,Inverse variance weighted,36,0.96 [0.84-1.10],0.548724659872135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,10,1.06 [0.90-1.25],0.483473972183625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.05 [0.53-2.08],0.898606003972647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,LGALS9,Galectin-9,Inverse variance weighted,39,0.97 [0.87-1.09],0.62669540376377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,Inverse variance weighted,12,1.65 [1.01-2.68],0.0446119443485286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,EGFLAM,Pikachurin,Inverse variance weighted,20,0.99 [0.90-1.08],0.824885280463492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,IL19,Interleukin-19,Inverse variance weighted,21,1.03 [0.92-1.15],0.614303115884058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CGA,Glycoprotein hormones alpha chain,Inverse variance weighted,3,3.56 [1.34-9.50],0.011058356638841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.04 [0.84-1.30],0.705471347226428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,MB,Myoglobin,Inverse variance weighted,10,0.95 [0.59-1.52],0.819763715918327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,FLT1,Vascular endothelial growth factor receptor 1,Inverse variance weighted,16,0.96 [0.82-1.13],0.625762138525138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PAM,Peptidyl-glycine alpha-amidating monooxygenase,Inverse variance weighted,44,0.90 [0.84-0.97],0.0039726039752286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CDH17,Cadherin-17,Inverse variance weighted,44,1.06 [0.96-1.16],0.273190770709986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,17,0.86 [0.72-1.02],0.0743260771033365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,REG1B,Lithostathine-1-beta,Inverse variance weighted,26,1.04 [0.89-1.21],0.638462632958363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,RTBDN,Retbindin,Inverse variance weighted,5,1.14 [0.82-1.57],0.437598448744012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PKD1,Polycystin-1,Inverse variance weighted,23,1.00 [0.86-1.17],0.995809048697418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SPP1,Osteopontin,Inverse variance weighted,19,1.17 [0.84-1.65],0.355146835058545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,10,0.83 [0.58-1.19],0.314678932527679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,3,0.78 [0.57-1.07],0.118033029354032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,LGALS4,Galectin-4,Inverse variance weighted,19,1.01 [0.89-1.15],0.871898192752533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,1.09 [0.98-1.21],0.0972376425273665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,27,0.94 [0.81-1.09],0.389577556626778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,1.91 [0.74-4.93],0.180600699608762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,11,1.19 [0.99-1.42],0.0614906964686398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SPARCL1,SPARC-like protein 1,Inverse variance weighted,62,1.01 [0.93-1.09],0.847133028465065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,54,0.97 [0.89-1.06],0.533469101559132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,VASN,Vasorin,Inverse variance weighted,19,1.01 [0.90-1.12],0.879208821790919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,10,1.20 [0.92-1.57],0.175167970317481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,25,1.07 [0.92-1.25],0.376065989968176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,MUC13,Mucin-13,Inverse variance weighted,13,0.89 [0.72-1.10],0.273479414955893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",Inverse variance weighted,40,1.02 [0.90-1.16],0.741516559821866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,LAYN,Layilin,Inverse variance weighted,23,0.89 [0.76-1.04],0.135493953913055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,TFF2,Trefoil factor 2,Inverse variance weighted,16,0.81 [0.64-1.01],0.0614600226060644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,11,1.12 [0.83-1.52],0.445476374785791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CALB2,Calretinin,Wald ratio,1,1.02 [0.42-2.49],0.965350018285984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,5,0.81 [0.60-1.09],0.167785547678214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,Inverse variance weighted,44,1.05 [0.99-1.11],0.113449907813045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,TREML2,Trem-like transcript 2 protein,Inverse variance weighted,19,1.03 [0.89-1.19],0.727868609829096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,31,1.01 [0.90-1.13],0.856876885258681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,DKK4,Dickkopf-related protein 4,Inverse variance weighted,18,1.01 [0.68-1.51],0.957371246106456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,1.07 [0.92-1.25],0.378343954588791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,RTN4R,Reticulon-4 receptor,Inverse variance weighted,26,1.06 [0.94-1.19],0.351102063569179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,DPY30,Protein dpy-30 homolog,Inverse variance weighted,2,1.01 [0.25-4.02],0.987315691248296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.09 [0.86-1.39],0.485496883121241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SEZ6L,Seizure 6-like protein,Inverse variance weighted,18,0.94 [0.76-1.16],0.555101824708775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CDH3,Cadherin-3,Inverse variance weighted,12,0.75 [0.57-1.01],0.0545227616262849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CCN5,CCN family member 5,Inverse variance weighted,12,0.85 [0.70-1.02],0.0847572609660187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,DSG2,Desmoglein-2,Inverse variance weighted,22,0.98 [0.80-1.19],0.826096407942322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,RNASET2,Ribonuclease T2,Inverse variance weighted,25,0.96 [0.85-1.08],0.476682253985353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CDH1,Cadherin-1,Inverse variance weighted,17,1.00 [0.79-1.26],0.97236224554262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,11,1.05 [0.72-1.54],0.796705687694903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CKB,Creatine kinase B-type,Inverse variance weighted,11,0.90 [0.58-1.40],0.64221505195882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,19,1.03 [0.90-1.19],0.643133195300647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Inverse variance weighted,2,1.31 [0.38-4.54],0.668567402671964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,NOTCH1,Neurogenic locus notch homolog protein 1,Inverse variance weighted,9,1.09 [0.93-1.27],0.282153201029805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,ADA2,Adenosine deaminase 2,Inverse variance weighted,18,1.22 [1.03-1.44],0.0186764087154347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,10,1.19 [0.69-2.07],0.532360366560245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,59,1.08 [0.98-1.19],0.100240523929938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,APOA2,Apolipoprotein A-II,Inverse variance weighted,16,1.05 [0.80-1.39],0.71449582101125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,12,1.12 [0.94-1.35],0.208976765156456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,DSC2,Desmocollin-2,Inverse variance weighted,16,0.78 [0.66-0.92],0.0026547613059773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SCN4B,Sodium channel subunit beta-4,Inverse variance weighted,27,0.94 [0.85-1.03],0.183440445941596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,NFASC,Neurofascin,Inverse variance weighted,19,0.91 [0.77-1.07],0.261820422675724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PCDH1,Protocadherin-1,Inverse variance weighted,5,1.21 [0.86-1.70],0.278090810806383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,GFRA2,GDNF family receptor alpha-2,Inverse variance weighted,27,0.90 [0.81-1.01],0.0703124092141772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,1.44 [0.91-2.27],0.123139728027644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,0.83 [0.59-1.17],0.297304733752369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CCL11,Eotaxin,Inverse variance weighted,11,1.05 [0.87-1.27],0.61202377126047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,22,1.00 [0.91-1.11],0.942832712773642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,30,1.17 [1.01-1.36],0.0351205017510443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,11,0.96 [0.71-1.29],0.794557367925055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CYTL1,Cytokine-like protein 1,Inverse variance weighted,10,0.98 [0.91-1.05],0.547856559037616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,RSPO1,R-spondin-1,Inverse variance weighted,14,0.99 [0.79-1.24],0.930710022426439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CSPG4,Chondroitin sulfate proteoglycan 4,Inverse variance weighted,17,1.08 [0.86-1.36],0.493996793907651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,FGF5,Fibroblast growth factor 5,Inverse variance weighted,43,1.00 [0.92-1.10],0.949990817712371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,LGALS1,Galectin-1,Inverse variance weighted,7,0.98 [0.84-1.16],0.847224177327482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,SNCG,Gamma-synuclein,Inverse variance weighted,49,0.91 [0.84-1.00],0.0535156865510415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,6,0.97 [0.75-1.26],0.807403319820541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,17,1.09 [0.95-1.25],0.231447346811187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,30,1.01 [0.85-1.19],0.949636802598638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CALB1,Calbindin,Inverse variance weighted,11,0.89 [0.61-1.30],0.552645208870571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,0.90 [0.67-1.21],0.501617904463791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,LMOD1,Leiomodin-1,Inverse variance weighted,6,0.92 [0.72-1.19],0.527727779804143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,ANG,Angiogenin,Inverse variance weighted,26,0.97 [0.86-1.10],0.633830164703628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,MMP3,Stromelysin-1,Inverse variance weighted,35,0.94 [0.83-1.06],0.295490439115732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CA12,Carbonic anhydrase 12,Inverse variance weighted,20,1.16 [1.00-1.36],0.0497355521494566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,18,1.01 [0.83-1.22],0.939873198005511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,18,0.94 [0.82-1.09],0.407132983625554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,VGF,Neurosecretory protein VGF,Inverse variance weighted,2,0.72 [0.36-1.44],0.351937483814944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,PRSS27,Serine protease 27,Inverse variance weighted,51,0.93 [0.85-1.01],0.095506648879312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,15,0.90 [0.83-0.99],0.0239513763881863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,ENDOU,Poly(U)-specific endoribonuclease,Inverse variance weighted,37,0.95 [0.82-1.11],0.524882661193274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CD302,CD302 antigen,Inverse variance weighted,17,0.90 [0.77-1.05],0.172759728836465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.37 [0.99-1.91],0.0604751377615224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CD93,Complement component C1q receptor,Inverse variance weighted,2,0.81 [0.40-1.63],0.547323867878431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,ENAH,Protein enabled homolog,Inverse variance weighted,2,0.74 [0.26-2.08],0.568972999515546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,DSG3,Desmoglein-3,Inverse variance weighted,27,1.00 [0.87-1.15],0.993760235278938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,MMP7,Matrilysin,Inverse variance weighted,15,0.95 [0.82-1.09],0.431356598440438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,22,1.09 [0.96-1.25],0.179261118558131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,KLK10,Kallikrein-10,Inverse variance weighted,17,0.90 [0.80-1.02],0.0875861822299607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,25,1.04 [0.91-1.21],0.546860380873484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,4,1.06 [0.82-1.37],0.644373014367801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,22,1.22 [1.03-1.46],0.0245176136681764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.12 [0.80-1.57],0.500049988832196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,9,1.02 [0.80-1.29],0.888241259555887
